Things We Do for No Reason™: Tumor markers CA125, CA19-9, and CEA in the initial diagnosis of malignancy

被引：1
作者：
Israilov, Sigal [1 ,2 ]
Cho, Hyung J. [1 ,3 ]
Krouss, Mona [1 ,2 ]
机构：
[1] New York City Hlth & Hosp, New York, NY 10037 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF HOSPITAL MEDICINE | 2022年 / 17卷 / 04期
关键词：
CARCINOEMBRYONIC ANTIGEN; PRACTICE GUIDELINE; CANCER BIOMARKERS; OVARIAN-CANCER; SERUM;
D O I：
10.12788/jhm.3645
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：303 / 305
页数：3
相关论文
共 15 条
  • [1] Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis
    Bergquist, John R.
    Ivanics, Tommy
    Storlie, Curtis B.
    Groeschl, Ryan T.
    Tee, May C.
    Habermann, Elizabeth B.
    Smoot, Rory L.
    Kendrick, Michael L.
    Farnell, Michael B.
    Roberts, Lewis R.
    Gores, Gregory J.
    Nagorney, David M.
    Truty, Mark J.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (04) : 475 - 482
  • [2] Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
    Dochez, Vincent
    Caillon, Helene
    Vaucel, Edouard
    Dimet, Jerome
    Winer, Norbert
    Ducarme, Guillaume
    [J]. JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [3] American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
    Gilligan, Timothy D.
    Seidenfeld, Jerome
    Basch, Ethan M.
    Einhorn, Lawrence H.
    Fancher, Timothy
    Smith, David C.
    Stephenson, Andrew J.
    Vaughn, David J.
    Cosby, Roxanne
    Hayes, Daniel F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3388 - 3404
  • [4] Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
    Goonetilleke, K. S.
    Siriwardena, A. K.
    [J]. EJSO, 2007, 33 (03): : 266 - 270
  • [5] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339
  • [6] Current and future biomarkers for pancreatic adenocarcinoma
    Loosen, Sven H.
    Neumann, Ulf P.
    Trautwein, Christian
    Roderburg, Christoph
    Luedde, Tom
    [J]. TUMOR BIOLOGY, 2017, 39 (06)
  • [7] Milovic Marijana, 2002, Med Sci Monit, V8, pMT25
  • [8] Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer
    Polat, E.
    Duman, U.
    Duman, M.
    Atici, A. E.
    Reyhan, E.
    Dalgic, T.
    Bostanci, E. B.
    Yol, S.
    [J]. CURRENT ONCOLOGY, 2014, 21 (01) : E1 - E7
  • [9] Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer Updated Guidelines From the European Group on Tumor Markers
    Soletormos, Gyorgy
    Duffy, Michael J.
    Abu Hassan, Suher Othman
    Verheijen, Rene H. M.
    Tholander, Bengt
    Bast, Robert C., Jr.
    Gaarenstroom, Katja N.
    Sturgeon, Catharine M.
    Bonfrer, Johannes M.
    Petersen, Per Hyltoft
    Troonen, Hugo
    CarloTorre, Gian
    Kulpa, Jan Kanty
    Tuxen, Malgorzata K.
    Molina, Raphael
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (01) : 43 - 51
  • [10] Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer
    Steele, Scott R.
    Chang, George J.
    Hendren, Samantha
    Weiser, Marty
    Irani, Jennifer
    Buie, W. Donald
    Rafferty, Janice F.
    [J]. DISEASES OF THE COLON & RECTUM, 2015, 58 (08) : 713 - 725
12